{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:26:05Z","timestamp":1775600765243,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001332","name":"CSIR","doi-asserted-by":"crossref","award":["01\/(2364)\/10\/EMR-II"],"award-info":[{"award-number":["01\/(2364)\/10\/EMR-II"]}],"id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UGC"},{"name":"SAP (DRS-1) UGC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejmech.2012.05.017","type":"journal-article","created":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T16:01:42Z","timestamp":1338048102000},"page":"397-402","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Highly regioselective synthesis of N-3 organophosphorous derivatives of\u00a03,4-dihydropyrimidin-2(1H)-ones and their calcium channel binding studies"],"prefix":"10.1016","volume":"54","author":[{"given":"Kamaljit","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawaljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Trappanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2012.05.017_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/jm00360a001","article-title":"New developments in calcium ion channel antagonists","volume":"26","author":"Janis","year":"1983","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1021\/jm00255a010","article-title":"Hantzsch-type dihydropyridine hypotensive agents","volume":"17","author":"Loev","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib3","first-page":"360","article-title":"Aldehyde-uridic derivative of ether acetyl and Diossalacetic","volume":"23","author":"Biginelli","year":"1893","journal-title":"Gazz. Chim. Ital."},{"key":"10.1016\/j.ejmech.2012.05.017_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/jm00106a048","article-title":"B.C.O\u2019Reilly, Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents","volume":"34","author":"Atwal","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib5","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/jm00171a044","article-title":"Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines","volume":"33","author":"Atwal","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0223-5234(00)01189-2","article-title":"Biologically active dihydropyrimidones of the Biginelli-type-a literature survey","volume":"35","author":"Kappe","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/138955709787001686","article-title":"Genesis of dihydropyrimidinone calcium channel blockers: recent progress in structure-activity relationships and other effects","volume":"9","author":"Singh","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib8","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejmech.2008.10.002","article-title":"N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity","volume":"44","author":"Singh","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib9","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1002\/ejoc.200900208","article-title":"An efficacious protocol for 4-Substituted 3,4-Dihydropyrimidinones: synthesis and calcium channel binding studies","author":"Singh","year":"2009","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib10","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1016\/j.tet.2009.03.060","article-title":"Chemical resolution of inherently racemic dihydropyrimidinones via a site selective functionalization of Biginelli compounds\u00a0with chiral electrophiles: a case study","volume":"65","author":"Singh","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2012.05.017_bib11","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1016\/j.tetlet.2006.09.039","article-title":"A\u00a0mild and practical method for the regioselective synthesis of N-acylated 3,4-dihydropyrimidin-2-ones. New acyl transfer reagents","volume":"47","author":"Singh","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2012.05.017_bib12","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.1016\/j.tet.2009.10.037","article-title":"N1, N3-Diacyl-3,4-dihydropyrimidin-2(1H)-ones neutral acyl group transfer reagents","volume":"65","author":"Singh","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2012.05.017_bib13","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1248\/cpb.35.3898","article-title":"Synthesis and antihypertensive activities of 1,4-Dihydropyridine-5-phosphonate derivatives","volume":"35","author":"Morita","year":"1987","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2012.05.017_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.2434996","article-title":"Why nature chose phosphates","volume":"235","author":"Westheimer","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2012.05.017_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1039\/a809398i","article-title":"Bioactive natural products with carbon phosphorus bonds and their biosynthesis","volume":"16","author":"Seto","year":"1999","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2012.05.017_bib16","first-page":"351","article-title":"Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents","volume":"5","author":"Lejczak","year":"1990","journal-title":"Anti-Cancer Drug Des."},{"key":"10.1016\/j.ejmech.2012.05.017_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical applications","volume":"5","author":"Colvin","year":"1999","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2012.05.017_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/cr960435y","article-title":"Binding energy and catalysis: the implications for transition-state analogs and catalytic antibodies","volume":"97","author":"Mader","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2012.05.017_bib19","first-page":"301","article-title":"Anticancer agents. Aminophosphonic acids of potential medical importance","volume":"1","author":"Kafarski","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/jm00001a017","article-title":"Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators","volume":"38","author":"Rovnyak","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.05.017_bib22","first-page":"H1049","article-title":"Effects of dihydropyridines on stress, myosin phosphorylation, and V0 in smooth muscle","volume":"252","author":"Moreland","year":"1987","journal-title":"Am. J. Physiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412003285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412003285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T23:36:28Z","timestamp":1687476988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523412003285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":21,"alternative-id":["S0223523412003285"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2012.05.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}